Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Altered mRNA expression levels of autophagy- and apoptosis-related genes in the FOXO pathway in schizophrenia patients treated with olanzapine

21 Jan 2021

Abstract excerpt

This study attempted to analyze the alterations in the mRNA expression levels of autophagy- and apoptosis-related genes in the forkhead box transcription factor O (FOXO) pathway in schizophrenia patients before and after olanzapine treatment. For a total of 32 acute schizophrenic inpatients, clinical data with PANSS were obtained before and after four weeks of olanzapine treatment (mean dose 14.24 ± 4.35 mg/d)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to FOXO transcription factor regulation
Share to Genetics and Neurodevelopmental Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33485989
DOI: 10.1016/j.neulet.2021.135669

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Altered mRNA expression levels of autophagy- and apoptosis-related genes in the FOXO pathway in schizophrenia patients treated with olanzapinePMID 33485989Read ↗

Alteration mRNA Expression Profile of Autophagy Related mTOR Pathway in Schizophrenic Patients with Olanzapine Treatment.Semantic proximity Read ↗

Autophagy-related gene model as a novel risk factor for schizophreniaSemantic proximity Read ↗

Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medicationSemantic proximity Read ↗

Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: Convergent pathway analysis findings from two independent samplesSemantic proximity Read ↗

Association of the genetic polymorphisms of metabolizing enzymes, transporters, target receptors and their interactions with treatment response to olanzapine in chinese han schizophrenia patients.Semantic proximity Read ↗

Autophagy has a key role in the pathophysiology of schizophreniaSemantic proximity Read ↗

Long non-coding RNAs in schizophrenia: Genetic variations, treatment markers and potential targeted signaling pathways.Semantic proximity Read ↗

Alterations in the Expression Levels of miR-9-5p and miR-4467 in Peripheral Blood of Patients with First-Episode SchizophreniaSemantic proximity Read ↗

Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia PatientsSemantic proximity Read ↗

Identification of serum microRNAs as diagnostic biomarkers for schizophreniaSemantic proximity Read ↗

Identification of Ferroptosis-Related Genes in Schizophrenia Based on Bioinformatic AnalysisSemantic proximity Read ↗

Association between Unc-51-like autophagy activating kinase 2 gene polymorphisms and schizophrenia in the Korean population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.